Vitamin E Pharmacokinetics and Biomarkers in Normal and Obese Women

PHASE1CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

October 10, 2014

Primary Completion Date

October 21, 2016

Study Completion Date

May 3, 2022

Conditions
DiabetesFatty LiverObesityHealthy Volunteers
Interventions
DRUG

Alpha tocopherol

intravenous deuterated vitamin E at doses of 2mg, 5mg, 7.5mg, 10mg and 30mg.

OTHER

Vitamin E

Deuterated vitamin E, oral and intravenous, at doses of 2mg, 5mg, 7.5mg, 10mg and 30mg.

OTHER

Vitamin C

Oral vitamin C, one gram daily.

Trial Locations (1)

20892

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors
lead

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

NCT00862433 - Vitamin E Pharmacokinetics and Biomarkers in Normal and Obese Women | Biotech Hunter | Biotech Hunter